image
Cyclo Therapeutics, Inc. CYTH
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 0.699
5.86 %
$ 20.1 M
Market Cap
-0.85
P/E
CASH FLOW STATEMENT
-16.2 M OPERATING CASH FLOW
-7.08%
Growth Rates
1Year -7.08%
3Years -23.75%
5Years -38.39%
7Years -27.52%
10Years -40.55%
-2.42 K INVESTING CASH FLOW
-6.34%
Growth Rates
1Year -6.34%
3Years 44.36%
5Years -1.43%
7Years -0.04%
10Years 34.03%
23.9 M FINANCING CASH FLOW
352373.00%
Growth Rates
1Year 352373.00%
3Years 8.67%
5Years 42.25%
7Years 54.71%
10Years 65.61%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cyclo Therapeutics, Inc.
image
Net Income -20.1 M
Depreciation & Amortization 19.3 K
Capital Expenditures -2.42 K
Stock-Based Compensation 737 K
Change in Working Capital 3.06 M
Others -9.36 K
Free Cash Flow -16.2 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
OPERATING CASH FLOW
Net Income (20.1) (15.5) (14.3) (8.9) (7.5) (4.3) (3.8) (4.2) (2.6) (0.6) 0.2 74.2 K 97.8 K 37.5 K (0.2) (0.4) 0.7 (0.1) (0.2) (0.6) 0.3 0.2 (0.1) (0.5)
Depreciation & Amortization 19.3 K 19.5 K 16.8 K 12.8 K 5.68 K 10.1 K 9.27 K 0.1 0.2 0.2 0.1 0.1 32.7 K 20.9 K 20.6 K 22.9 K 24.4 K 27.5 K 35 K 27.8 K 37.8 K 24.2 K 51.3 K 26.4 K
Deferred Income Tax 0 0 0 74.7 K 0 51.9 K 50.8 K 0.9 0.1 88.3 K 80 K 25 K 91.8 K 25 K 76 0.2 (0.5) 0 0.2 0 (0.2) 0 0 0.2
Stock Based Compensation 0.7 0.5 0.5 0.3 0.4 83.4 K 0.1 0.1 74.6 K 0.2 40 K 22 K 0.1 0.2 0.3 0.2 0 0 0 0 0 0 0 0
Other Operating Activities 52.9 K (0.1) 21.9 K 74.7 K 13.3 K 64 K 53.5 K 3.3 K 0.1 88.3 K 93.5 K 16.9 K 97.8 K 15.9 K 20.8 K 92.2 K 0.1 0.1 0.2 0.7 54.9 K 37 K 56.1 K 82.9 K
Change in Working Capital 3.1 48.2 K (1.2) 0.1 0.5 1.0 0.6 0.1 57 K (0.4) 9.87 K (0.2) 0.1 22.6 K 35.6 K 45.8 K 11 K 47.9 K 23.3 K 81.2 K 97.7 K (0.2) 16.9 K 0.2
Cash From Operations (16.2) (15.1) (15.0) (8.5) (6.6) (3.2) (3.1) (3.0) (2.0) (0.6) 0.6 58.5 K 0.2 0.2 0.1 64.7 K 0.4 26.1 K 0.1 0.2 65 K 48.1 K 23.4 K 28.7 K
INVESTING CASH FLOW
Capital Expenditures 2.42 K 15.1 K 22.5 K 53.1 K 1.32 K 2.96 K 6.86 K 9.34 K (0.4) (0.2) (0.2) (0.2) (0.6) (0.4) 43.4 K 84.4 K 84.3 K 27.6 K 22.6 K 80.9 K 54.7 K 17.9 K 9.3 K 97 K
Other Items 0 53.3 K 37.3 K 39.1 K 37.5 K 35.9 K 39.1 K 1.0 700 0 2 K 0 0 0 6.71 K 0.2 (0.1) 20.8 K (0.1) 3.05 K 11.2 K 748 9.69 K 18.3 K
Cash From Investing Activities 2.42 K 38.2 K 14.8 K 14 K 36.1 K 32.9 K 32.2 K 0.9 (0.4) (0.2) (0.2) (0.2) (0.6) (0.4) 36.7 K 0.2 (0.2) 6.79 K (0.1) 83.9 K 65.9 K 17.1 K 392 78.7 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.23 K 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 6.78 K 6.78 K 0.2 0 0 0 (0.8) 40.5 K 57.3 K (0.1) 46.6 K 0.4 1.02 K 0 (0.2) 13.2 K 26.7 K 54.2 K 38.4 K 37.6 K 14.8 K 14.5 K 20.6 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 14.2 0 0 0 0.1 0 0 0 0 50 K 21.7 K 0 9.5 K 469 0 0 16.5 K 0 0 0 0 21.9 K 0 0
Cash From Financing Activities 23.9 6.78 K 18.8 18.6 7.1 4.1 3.3 1.1 1.9 2.9 (0.2) 3.43 K 0.4 7.2 K 9.23 K (0.2) 29.7 K 26.7 K 54.2 K 34.9 K 37.6 K 7.05 K 14.5 K 50.6 K
CHANGE IN CASH
Net Change In Cash 7.7 (15.1) 3.8 10.1 0.6 0.9 0.3 (0.9) (0.5) 2.1 0.2 (0.1) 20.3 K (0.2) 62.2 K 66.7 K 0.2 7.4 K 63.3 K 86.6 K 38.5 K 38.1 K 8.5 K 56.7 K
FREE CASH FLOW
Free Cash Flow (16.2) (15.1) (15.0) (8.6) (6.6) (3.2) (3.1) (3.0) (2.4) (0.8) 0.4 (0.1) (0.4) (0.2) 64.7 K 19.7 K 0.3 1.51 K 0.1 0.1 10.2 K 30.3 K 32.7 K (0.1)